Improved Expression of Aggregation-Prone Tau Proteins Using a Spidroin-Derived Solubility Tag
Open Access
- 25 June 2024
- journal article
- research article
- Published by MDPI AG in Separations
- Vol. 11 (7) , 198
Abstract
Tauopathies, a group of neurodegenerative disorders, are characterized by the abnormal aggregation of microtubule-associated Tau proteins in neurons and glial cells. The process of Tau proteins transitioning from soluble, intrinsically disordered monomers to disease-associated aggregates is still unclear. Investigating these molecular mechanisms requires the reconstitution of such processes in cellular and in vitro models using recombinant proteins at high purity and yield. However, the production of phase-separating or aggregation-prone recombinant proteins like Tau’s hydrophobic-rich domains or disease mutation-carrying variants on a large scale is highly challenging due to their limited solubility. To overcome this challenge, we have developed an improved strategy for expressing and purifying recombinant Tau proteins using the major ampullate spidroin-derived solubility tag (MaSp-NT*). This approach involves using NT* as a fusion tag to enhance the solubility and stability of expressed proteins by forming micelle-like particles within the cytosol of E. coli cells. We found that fusion with the NT* tag significantly increased the solubility and yield of highly hydrophobic and/or aggregation-prone Tau constructs. Our purification method for NT* fusion proteins yielded up to twenty-fold higher amounts than proteins purified using our novel tandem-tag (6xHis-SUMO-Tau-Heparin) purification system. This enhanced expression and yield were demonstrated with full-length Tau (hT40/Tau441), its particularly aggregation-prone repeat domain (Tau-MTBR), and Frontotemporal dementia (FTD)-associated mutant (Tau-P301L). These advancements offer promising avenues for the production of large quantities of Tau proteins suitable for in vitro experimental techniques such as nuclear magnetic resonance (NMR) spectroscopy without the need for a boiling step, bringing us closer to effective treatments for tauopathies.Keywords
Funding Information
- National Research, Development and Innovation Office (K124670, K131702, 11D0122N, FWOSB72)
- FWO PhD fellowships in fundamental research (K124670, K131702, 11D0122N, FWOSB72)
- Strategic Basic Research (K124670, K131702, 11D0122N, FWOSB72)
This publication has 68 references indexed in Scilit:
- A systematic review about affinity tags for one-step purification and immobilization of recombinant proteins: integrated bioprocesses aiming both economic and environmental sustainability3 Biotech, 2023
- A Novel Approach for the Production of Aggregation-Prone Proteins Using the Spidroin-Derived NT* Tag2022
- Soluble expression of single-chain variable fragment (scFv) in Escherichia coli using superfolder green fluorescent protein as fusion partnerApplied Microbiology and Biotechnology, 2019
- Production of recombinant tau oligomers in vitro2017
- Overview of the Purification of Recombinant ProteinsCurrent Protocols in Protein Science, 2015
- SUMO as a Solubility Tag and In Vivo Cleavage of SUMO Fusion Proteins with Ulp12014
- Structural transitions in tau k18 on micelle binding suggest a hierarchy in the efficacy of individual microtubule‐binding repeats in filament nucleationProtein Science, 2013
- Tau and Tauopathies2012
- Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategiesMolecular and Cellular Biochemistry, 2007
- The CCPN data model for NMR spectroscopy: Development of a software pipelineProteins: Structure, Function, and Bioinformatics, 2005